Use of HGF for the manufacture of a medicament for treating fibrotic disorders

摘要

Hepatocyte Growth Factors (HGFs) for use in the treatment of fibrosis disorders selected from the group consisting of arterial sclerosis, progressive systemic sclerosis (PSS), cystic fibrosis, chronic graft versus host disease, local and systemic scleroderma, Peyornie's disease, penis fibrosis, urethrostenosis after the test using a cystoscope, myelofibrosis and idiopathic retroperitoneal fibrosis.